Company profile: Singular Bio
1.1 - Company Overview
Company description
- Provider of single molecule detection technology enabling single-molecule analysis of a patient's DNA with high sensitivity for detecting many common conditions, aimed at expanding access to fundamental healthcare information by making advanced genetic tests available to everyone.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Singular Bio
Microsynbiotix
HQ: Ireland
Website
- Description: Provider of technology to eliminate excessive antibiotic use in farmed fish by engineering microalgae, leveraging advances in algal genomics and molecular biology to express inexpensive therapeutic proteins and vaccines of economic value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microsynbiotix company profile →
Health in Code
HQ: Spain
Website
- Description: Provider of genetic diagnosis and testing services for inherited diseases, with expertise in inherited cardiovascular conditions. Services include full NGS testing from DNA reception to specialized clinical reports, in-house sequencing kits with bioinformatics and variant database, variant interpretation per guidelines, multidisciplinary clinical genetic reports, specialist genetic counseling, and proteomics as a certified Olink Explore service provider.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health in Code company profile →
Clear Labs
HQ: United States
Website
- Description: Provider of biotechnology solutions that integrate a genomics system to simplify diagnostics for the clinical and application sectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clear Labs company profile →
SNIPR Biome
HQ: Denmark
Website
- Description: Provider of CRISPR-based microbial gene therapies that selectively target and eliminate hazardous bacteria without harming beneficial microbes; gut-directed gene therapy via engineered bacteria; CRISPR-Guided Vectors (CGV) for rapid, precise bacterial killing; platforms for in situ therapeutic protein and peptide production; backed by an extensive patent portfolio and research collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SNIPR Biome company profile →
Megazyme
HQ: Ireland
Website
- Description: Provider of analytical enzymes, chromogenic substrates, high-purity polysaccharides and colourimetric oligosaccharides; assay kits including Rapid Integrated Total Dietary Fiber and Lactose Assay; and Food Safety Division dehydrated culture media and diagnostic tests for foodborne bacteria, natural toxins, genetic modifications and allergens, serving laboratories in food & beverages, biofuel, animal feed, wine & brewing, dairy and cereals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Megazyme company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Singular Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Singular Bio
2.2 - Growth funds investing in similar companies to Singular Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Singular Bio
4.2 - Public trading comparable groups for Singular Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →